Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.
Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles. To find out more, check out the podcast from which this hour was drawn: “How Are Psychedelics and Other Party Drugs Changing . . .
We have always been a nation of drinkers — but now there are more daily users of cannabis than alcohol. Considering alcohol’s harms, maybe that’s a good thing. But some people worry that the legalization of cannabis has outpaced the research. (Part one of a four-part series.)
You want to listen to Freakonomics Radio? That’s great! Most people use a podcast app on their smartphone. It’s free (with the purchase of a phone, of course). Looking for more guidance? We’ve got you covered.
Stay up-to-date on all our shows. We promise no spam.
